Literature DB >> 22673792

Decreased heart rate variability in patients with psoriatic arthritis.

Inna Gaydukova1, Andrey Rebrov, Natalia Nikitina, Denis Poddubnyy.   

Abstract

The purpose of this study was to investigate autonomous regulation of the cardiac activity by means of the heart rate variability (HRV) assessment and possible influence of conventional cardiovascular risk factors and disease activity parameters on it in patients with psoriatic arthritis (PsA). In total, 38 patients with the reliable diagnosis of PsA without clinically manifest cardiovascular pathology, known rhythm or conduction disturbances, diabetes mellitus, and hypercholesterolemia were included. In the control group, 25 age- and sex-matched healthy persons comparable with PsA patients in cardiovascular risk profile were included. For the HRV analysis, we used 5-min-long ECG records obtained at rest. Time and frequency domain parameters of HRV were calculated. Patients with PsA had decreased HRV in comparison to healthy controls as reflected by decrease of the standard deviation of normal R-R intervals (65.1 ± 66.8 vs. 83.2 ± 43.3 ms, respectively, p = 0.011), of the percentage of normal R-R intervals that differ by more than 50 ms (12.9 ± 15.4 vs. 20.6 ± 17.1 %, respectively, p = 0.035), and of the total power (2,069.4 ± 1,537.8 vs. 2,942.5 ± 1,734.2 ms(2), respectively, p = 0.006). A significant correlation of HRV parameters with disease duration and parameters of disease activity in PsA was found. Patients with PsA had impaired autonomous regulation of the cardiac activity, which is likely to be related to the presence of systemic inflammation and which could contribute to the increase of cardiovascular risk in this disease.

Entities:  

Mesh:

Year:  2012        PMID: 22673792     DOI: 10.1007/s10067-012-2015-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.

Authors:  C Bengtsson; M-L Ohman; O Nived; S Rantapää Dahlqvist
Journal:  Lupus       Date:  2011-11-07       Impact factor: 2.911

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

3.  C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease.

Authors:  A Sajadieh; O W Nielsen; V Rasmussen; H O Hein; J F Hansen
Journal:  J Intern Med       Date:  2006-10       Impact factor: 8.989

4.  [Heart rate variability in patients with ankylosing spondilitis (Bekhterev's disease)].

Authors:  D A Poddubnyĭ; I Z Gaĭdukova; A P Rebrov
Journal:  Ter Arkh       Date:  2009       Impact factor: 0.467

Review 5.  Chronic inflammatory diseases and cardiovascular risk: a systematic review.

Authors:  Idan Roifman; Paul L Beck; Todd J Anderson; Mark J Eisenberg; Jacques Genest
Journal:  Can J Cardiol       Date:  2011 Mar-Apr       Impact factor: 5.223

6.  The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991.

Authors:  M Shbeeb; K M Uramoto; L E Gibson; W M O'Fallon; S E Gabriel
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

7.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

8.  Cardiovascular morbidity in psoriatic arthritis.

Authors:  D D Gladman; M Ang; L Su; B D M Tom; C T Schentag; V T Farewell
Journal:  Ann Rheum Dis       Date:  2008-08-12       Impact factor: 19.103

9.  Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.

Authors:  Ahmad Sajadieh; Olav Wendelboe Nielsen; Verner Rasmussen; Hans Ole Hein; Sadollah Abedini; Jørgen Fischer Hansen
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

10.  Heart rate variability in patients with rheumatoid arthritis.

Authors:  Harun Evrengül; Dursun Dursunoglu; Veli Cobankara; Bülent Polat; Deniz Seleci; Sibel Kabukçu; Asuman Kaftan; Ender Semiz; Mustafa Kilic
Journal:  Rheumatol Int       Date:  2003-09-11       Impact factor: 2.631

View more
  2 in total

1.  Heart rate variability in familial Mediterranean fever patients.

Authors:  Hakan Kaya; Arif Süner; Sedat Köroğlu; Ahmet Akçay; İbrahim Halil Türkbeyler; Murat Köleoğlu
Journal:  Eur J Rheumatol       Date:  2014-06-01

2.  The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial.

Authors:  Salome Kristensen; Erik Berg Schmidt; Annette Schlemmer; Claus Rasmussen; Esther Lindgreen; Martin Berg Johansen; Jeppe Hagstrup Christensen
Journal:  Lipids Health Dis       Date:  2016-12-12       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.